Pegasys Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitis B Patient
Condition:   Hepatitis B Virus Interventions:   Biological: Human Serum Albumin/interferon alpha2b fusion protein;   Biological: Pegasys Sponsor:   Tianjin SinoBiotech Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2017 Category: Research Source Type: clinical trials